Severe spinal cord injury (SCI) can cause neurological dysfunction and paralysis. However, the early dynamic changes of neurons and their surrounding environment after SCI are poorly understood. Although methylprednisolone (MP) is currently the standard therapeutic agent for treating SCI, its efficacy remains controversial. The purpose of this project was to investigate the early dynamic changes and MP's efficacy on axonal damage, blood flow, and calcium influx into axons in a mouse SCI model. YFP H-line and Thy1-GCaMP transgenic mice were used in this study. Two-photon microscopy was used for imaging of axonal dieback, blood flow, and calcium influx post-injury. We found that MP treatment attenuated progressive damage of axons, increased blood flow, and reduced calcium influx post-injury. Furthermore, microglia/macrophages accumulated in the lesion site after SCI and expressed the proinflammatory mediators iNOS, MCP-1 and IL-1b. MP treatment markedly inhibited the accumulation of microglia/ macrophages and reduced the expression of the proinflammatory mediators. MP treatment also improved the recovery of behavioral function post-injury. These findings suggest that MP exerts a neuroprotective effect on SCI treatment by attenuating progressive damage of axons, increasing blood flow, reducing calcium influx, and inhibiting the accumulation of microglia/macrophages after SCI.
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S
pinal cord injury (SCI) is a devastating medical problem that causes serious disability and paralysis. Approximately 40 million people worldwide experience SCI every year 1 . The primary injury is caused by traumatic spinal cord damage 2 . The secondary injury can destroy nearby neurons that were not damaged during the primary injury 3 . After the initial damage of the blood vessels in a spinal cord region, secondary injury causes a fall in microvascular blood flow that leads to ischemia and hypoxia, which exacerbate the primary injury 4 . In previous studies, spinal cord blood flow was often measured by Doppler ultrasound 5 . However, Doppler ultrasound can only measure blood vessels of approximately 100 mm in diameter 6 , damage to regional microvascular blood flow proximal to lesion site remains poorly understood. In addition, an increase in intracellular free [Ca 21 ] results in the activation of the calcium-activated protease calpain, which is involved in neuronal apoptosis 7 . However, the changes of calcium influx in injured axons of living animal after SCI remains unclear. Furthermore, the role of microglia in SCI has been controversial with both beneficial and destructive effects 8 . Microglia can phagocytose cellular debris after SCI. They also can infiltrate and accumulate at the injured epicenter and secrete proinflammatory cytokines, which may aggravate secondary SCI 9 . To reduce secondary injury after SCI, clinical and experimental studies have been conducted to block the development of these abnormalities. Ecto-domain phosphorylation 10 and fluoxetine treatment 11 have been reported as potential methods for functional recovery after SCI. Although the effects of these therapeutic regimens are compelling, their clinical applications are limited. After the first demonstration of the experimental efficacy of high dose methylprednisolone (MP) in acute experimental SCI 12 , MP has been widely used in clinical treatment for SCI patients 13 . However, recent retrospective cohort studies have demonstrated a lack of statistical difference between SCI patients treated with and without MP 14 . The efficacy of MP in SCI treatment remains controversial.
In previous laboratory studies, axons were assessed by biotinylated dextran amine (BDA) tract tracing 15 , and the intracellular calcium concentration in the injured spinal cord was measured using the techniques of La 31 blockage and atomic absorption spectroscopy 16 . For these in vitro methods, tissue must be extracted from the spinal cord. For these reasons, the early dynamic changes of SCI and MP's effect governing secondary injury remain unclear. In the present study, we took advantage of two-photon microscopy and spinal cord implanted window, which are able to image axonal dieback in the living mouse spinal cord over multiple hours. We also performed in vivo imaging of the regional microvascular blood flow and calcium influx into axons at the edge of lesion site 17 . These in vivo methods allowed us to further our understanding of early dynamic changes, as well as MP's effect on axonal damage, microvascular blood flow, and calcium influx into axons after SCI.
Results
MP attenuated axonal damage and neuronal death. We used twophoton microscopy to image the axonal dieback in the living mouse spinal cord and investigate the effect of MP treatment after hemisection SCI (Fig. 1) . Our results showed that the axons in the sham group (n 5 6) remained intact during all imaging sessions after surgery. The severed axons dieback from the initial lesion site over time after hemisection injury ( Fig. 2A) . We first imaged the injured axons at 30 min post-injury and measured the axonal dieback distance from the initial lesion site. The respective axonal average dieback distances from the initial lesion site at 8 h, 24 h and 48 h (Fig. 2C) . At each time point, the saline-treated group exhibited a greater axonal dieback distance than the MP-treated group (P , 0.01 for all). To investigate the pathological changes and MP's effect on deep tissue after SCI, we measured the number of neurons at the edge of lesion site 3 days post-injury (Fig. 2B) . The number of neurons was 48.71 6 7.26 cells/mm 2 in the saline-treated group (n 5 6) and 80.21 6 5.76 cells/mm 2 in the MP-treated group (n 5 6). The number of neurons was greater in the MP group than in the saline group (Fig. 2D , P 5 0.007).
MP increased regional microvascular blood flow and reduced microvessel loss. We used in vivo two-photon imaging of microvessels proximal to the lesion site (Fig. 3A) to measure microvascular blood flow velocity and vascular lumen diameter at different time point (Fig. 3B ) and investigate the effect of MP treatment after SCI 18, 19 . Our results showed that the blood flow velocity in the sham group (n 5 6) remained stable during all imaging sessions after surgery (Figs 3C and 3F). The regional spinal cord blood flow velocity decreased progressively after hemisection SCI in the saline-treated SCI group. The respective microvascular blood flow velocity at 30 min, 60 min, 90 min, and 120 min post-injury were 1635.01 6 568.47 mm/s, 1435.77 6 566.32 mm/s, 1175.82 6 455.23 mm/s, and 1074.92 6 399.64 mm/s in the saline-treated SCI group (n 5 6). However, the regional spinal cord blood flow exhibited a sustained increase post-injury in the MPtreated SCI group. The respective microvascular blood flow velocity 34 6 579 .88 mm/s in the MP-treated SCI group (n 5 6). The regional spinal cord blood flow velocity was significantly higher in the MP group than in the saline group (Fig. 3F, P , 0.05) . However, the vascular lumen diameter in all groups exhibited no significant changes at 30 min, 60 min, 90 min, and 120 min post-injury (P . 0.05, Fig. 3E ). We also examined the number of microvessels at the edge of lesion site at 3 days post-injury (Fig. 3D) . The number of microvessels were 167.2 6 12.65 vessels/mm 2 in the saline-treated Values presented are mean 6 SEM. *P , 0.01, P 5 0.007. Statistical comparision was done using Student's t test.
www.nature.com/scientificreports group (n 5 6), and 231.8 6 10.86 vessels/mm 2 in the MP-treated group (n 5 6). The saline group exhibited greater blood vessel loss than the MP group ( Fig. 3G , P 5 0.008). These results suggest that MP treatment can ameliorate microcirculation by increasing regional microvascular blood flow and reducing microvessels loss, which may contribute to the attenuation of progressive axonal damage and neuronal death.
MP reduced calcium influx and the expression of active calpain-1 and cleaved caspase-3. We used two-photon microscopy and Thy1-GCaMP transgenic mice to image the level of intracellular calcium [Ca 21 ] i with a genetically-encoded calcium indicator GCaMP in injured axons in order to assess the effect of MP on calcium influx after SCI (Fig. 4A) 21 ] i in MP group were significantly lower than the saline group at 60 min, 90 min, and 120 min post-injury ( Fig. 4C , P , 0.05). In order to assess the expression of calpain-1 gene and its apoptotic pathways that are downstream of increased [Ca 21 ] i , we measured changes in active calpain-1 and cleaved caspase-3 post-injury by Western blots analysis (Fig. 4B ). Compared with saline treatment, MP treatment down-regulated the expression of calpain-1 and active caspase-3 in injured spinal cord segments ( Fig. 4D , P , 0.05).
MP inhibited the accumulation of microglia/macrophages, and down-regulated the expression of iNOS, MCP-1, and IL-1b. We examined the number of microglia/macrophages, and MP's effect on their accumulation at the lesion sites 3 days post-injury (Fig. 5A ). The number of microglia/macrophages at the lesion site was 83.69 6 9.06 cells/mm 2 in the saline-treated SCI group (n 5 6) and 46.67 6 6.41 cells/mm 2 in the MP-treated SCI group (n 5 6). The number of microglial/macrophages was greater in the saline group than in the MP group ( no ankle movement and complete hind limb paralysis after hemisection SCI (BMS score 0). A few mice were capable of slight ankle movement during D7 post-injury in saline and MP groups, but there was no significant difference in BMS score (P . 0.05). The respective BMS scores at 30D, 60D, and 90D post-injury were 1.17 6 0.98, 1.51 6 1.22, 1.83 6 1.16 in the saline-treated SCI group (n 5 6), and 2.51 6 1.05, 3.16 6 1.16, 3.50 6 1.04 in the MP-treated SCI group (n 5 6). The BMS score was significantly higher in MP-treated group than in saline-treated group from 30 D, 60 D, and 90 D after SCI (P , 0.05).
Discussion
Spinal cord injury includes primary and secondary injury phases. The primary injury phase comprises immediate cell death and vascular dysfunction, and is followed by a delayed secondary injury phase that can last from hours to weeks. Secondary injury triggers a wide range of down-stream pathological events that aggravate the primary injury, and causes progressive cell damage that is not involved in the primary injury 21 . However, the early pathological changes of axonal dieback, blood flow, and calcium influx into axons in vivo after SCI remain unclear. To explore the pathogenic mechanism of SCI, we conducted this study to investigate the early pathological changes of axonal dieback, blood flow and calcium influx into axons in vivo after SCI.
As the standard effective therapeutic agent now in use for the clinical treatment of acute SCI, the glucocorticoid drug MP has been shown to alleviate secondary injury by decreasing inflammation and ischemic reaction, as well as by inhibiting lipid peroxidation 22 . However, high-dose MP can cause many side effects, including infection, pneumonia, bleeding, and femoral head necrosis, and thus increase the risk of death 23, 24 . In addition, some retrospective cohort studies have shown no differences in neurological outcome between SCI patients with or without MP therapy 14 . The use of high-dose MP in SCI patients is controversial on the basis of the risk of serious adverse effects and modest neurological benefit. In clinical treatment for SCI patients, MP is recommended to be administered within 8 h post-injury 25 . Previous study indicated that MP therapy on SCI model had a very short therapeutic window, the delayed treatment of MP showed no effect compared to the saline-treated group 26 . In the present study, MP was initially administered at 30 min postinjury and continuous administered at 6 h and 24 h to provide an effective concentration during the first day after SCI. Our study confirmed that the early application of MP was effective at reducing the post-SCI damage during the early stage and improved functional recovery at the later stage. These results consisted with previous study that MP treatment improved axonal survival and sprouting in complete transection SCI model 27 . Previous laboratory studies of SCI were mostly confined to vitro experimental techniques, including tissue sectioning, immunohistochemistry, and BDA labeling 28 . These methods do not allow us to determine dynamic changes in the same animal over multiple days after SCI. The in vivo imaging techniques used in the past include MRI, micro-CT, diffusion tensor tractography 29 , any of which can be used to examine the same animal for a couple of days. However, these methods lack resolution at the micrometer level. Recent, two-photon microscopy has been used to examine pinprick-induced or laserinduced SCI models [30] [31] [32] [33] [34] . These models are able to control the damage in axons without damaging the neighboring neurons and vessels. In the present study, we used a hemisection SCI model, in which axons, neurons, and vessels can be damaged. We also modified a spinal stabilization device and implanted window that reduces the movement artifacts caused by heartbeat and breathing (Fig. 1) , allowing us to examine axonal dieback, regional microvascular blood flow, and calcium influx into axons in the same animal for multiple hours. This in vivo imaging method allows us to evaluate the early dynamic changes and MP's effect after SCI in a less invasive manner.
Although previous study showed that MP therapy may reduce lesion volume after SCI 35 , the mechanisms underlying MP therapy remain unclear. In the present study, we conducted two-photon microscopy and employed YFP H-line transgenic mice to trace axonal dieback after hemisection SCI. Our results indicated that the axons in the sham group remained intact during all imaging sessions post-surgery. This finding indicated that the window implantation on the spinal cord did not cause significant damage to the axons. In the hemisection SCI groups, MP treatment reduced axonal dieback distance at 48 h post-injury when compared with the saline-treated mice. The histology revealed that the MP group also had a higher neuronal number than the saline group. In addition, MP improved the functional recovery at the later stage of SCI. These findings suggest that MP therapy may help attenuate progressive axonal damage and neuronal death, improve neurological recovery after SCI. These findings supported the idea that the early application of MP improved the neuronal viability and promoted neurite outgrowth after SCI 36, 37 . Previous studies often used Doppler ultrasound to evaluate the blood flow after SCI 4 . It is difficult to detect the microvascular blood flow at the edge of injured epicenter using this method. In this study, we conducted in vivo two-photon imaging of microvessels of 10-20 mm diameter labeled with Texas Red dextran and measured the blood flow velocity for several hours post-injury. Our results revealed that the microvascular blood flow velocity and vascular lumen diameter in the uninjured sham group remained stable during all imaging sessions after surgery, this finding suggested that the implanted window on the spinal cord did not cause significant damage to the microvessels and the blood flow. In addition, the microvascular blood flow velocity in saline-treated group decreased progressively post-injury. Thrombus, and dysfunction of vascular homeostasis might be important contributors to this event 38 . However, microvascular blood flow velocity was significantly increased in the MP-treated group compared with the saline-treated group. These results consisted with the previous findings that MP treatment after SCI improved microvascular perfusion 39 . However, the vascular lumen diameter in all groups exhibited no significant changes at all imaging sessions post-injury. Thus, the increase blood flow is not due to vasospasm and vasodilatation-induced hyperemia in the monitored venules. Histology also showed that MP-treated mice had a higher microvessels number at the edge of lesion site than saline-treated mice, which suggests that high-dose MP treatment reduces microvessels loss after SCI.
The initial trauma in the spinal cord disrupts the cell membrane and axolemma, leading to a sudden influx of extracellular calcium. It also causes mitochondrial damage that can affect Na-K-ATPase activity, as well as an increase of intracellular calcium via dysfunction of Na-Ca-exchanger 40 . The intracellular calcium concentration activates the calcium-activated neutral proteinase calpain-1, which results in neuronal disintegration and apoptosis 41 . These are essential pathogenic factors in the secondary phase of SCI. To understand how MP affects calcium influx in injured axons, we used Thy1-GCaMP transgenic mice, which express genetically encoded calcium indicators in neurons and axons. Two-photon microscopy was used to image the calcium influx in injured axons post-injury. MP treatment produced a significant reduction of calcium influx compared with the saline-treated group post-injury. The expression of active calpain-1 and cleaved caspase-3 were down-regulated in MP-treated mice compared with saline-treated mice. These findings may suggest that the membrane-stabilization effects of MP prevent excessive calcium influx into cells 42 . MP also reduced the expression of active calpain-1 and cleaved caspase-3 post-injury 43 . These changes of expression might be the important factors of how MP reduces secondary injury after SCI.
Microglia are the resident immune cells in the spinal cord. When traumatic damage is inflicted on the spinal cord, the blood-spinal cord barrier is damaged. Microglia/macrophages were recruited and accumulated at the lesion site after SCI and secreted proinflammatory cytokines that cause neuronal toxicity [44] [45] [46] . The proinflammatory mediators iNOS, MCP-1, and IL-1b are strongly associated with neurologic impairment. NO and ATP mediated the conversion of microglial shape from ramified to ameboid indicating cellular activation 33 . Activated microglia/macrophages induced axonal dieback through direct physical interactions 47 . In this study, we found that microglia/macrophages accumulated at the site of injury after SCI, and MP treatment inhibited the accumulation of microglia/macrophages, down-regulated the expression of iNOS, MCP-1 and IL-1b. This also might be a major point of the mechanism underlying the beneficial neuroprotective effect of MP in this model of acute SCI.
In conclusion, our data demonstrate that MP exerts a protective effect during the early stages of hemisection SCI in this mouse model. Our findings are consistent with previous studies that MP therapy may alleviate the progressive damage of axons and reduce accumulation of microglia/macrophages 48 . However, we used hemisection injury model rather than compression injury model. The difference of the injury model might be a major reason which caused different results. In addition, we observed a longer period to assess functional improvement of the animals and found that MP treatment improved the recovery of behavioural function after SCI. Our results further suggest that MP increase microvascular blood flow and reduce microvessel loss, reduce calcium influx and down-regulate the expression of active calpain-1 and cleaved caspase-3, and downregulate the expression of iNOS, MCP-1 and IL-1b. These findings suggest that early application of MP may be an effective treatment for acute SCI.
Lastly, it is important to point out some limitations of our studies related to repeated imaging with in vivo two-photon microscopy. There was mild inflammatory responses caused by the implanted window as previous described by Farrar and our preliminary experiment 49 . Previous studies showed that even a minimal injury to the spinal cord caused enormous increase in microglia number and density around the lesion site. However, this increase far exceeded the microglia response caused by implanted window. This moderate inflammatory reaction does not seem to significantly affect the results caused by MP treatment after SCI. In present study, all animals were treated in the same condition and experienced the same model, this could help to minimize the variance between groups. In addition, the two-photon microscopy can only image axons less than 200 mm deep in the dorsal columns, it is difficult to image the deeper tissue in live mouse spinal cord. The growth of granulation tissue also affect the quality of image 34 . Furthermore, there are a number of effects of MP on spinal cord injury treatment. It is not clear which of these is responsible for the therapeutic effect. Further research needs to address these issues.
Methods
Animals. Animal surgical procedures were conducted with the approval of the Animal Experimentation Ethics of the Chinese PLA General Hospital. All experiments were carried out in accordance with Animal Experimentation Ethics Guidelines of the Chinese PLA General Hospital. Animals had free access to food and water. Two lines of transgenic mice, the YFP H-line and the Thy1-GCaMP line (male, 8-10 weeks of age, 20-25 g) were used in this study. YFP-H line mice specifically expressed yellow fluorescent protein (YFP) in motor and sensory neurons and axons 50 . Thy1-GCaMP transgenic mice expressed a genetically encoded GFP-based calcium indicator protein in motor and sensory neurons and axons 17, 51 . We implanted the glass window after laminectomy or hemisection injury to the spinal cord. Then we randomly divided each mouse line into three groups (n 5 6 mice per subgroup). The sham group, the saline-treated SCI group and the MP-treated SCI group each included YFP-H line mice (n 5 6 per group) and Thy1-GCaMP mice (n 5 6 per group). The sham group received laminectomy only. The saline-treated SCI group received saline intraperitoneally at 30 min, 6 h, 24 h after SCI. The MP-treated SCI group received MP intraperitoneally at 30 min, 6 h, 24 h after SCI. MP was administered at doses of 30 mg/kg, as recommended by the National Acute Spinal Cord Injury Study (NASCIS) 2, 3 trials and as reported previously 13, 25, 52 . The criteria for animal exclusion. During the surgery process, two YFP-H line mice died due to inappropriate anesthesia, we added other two YFP-H line mice (male, 8-10 weeks of age, 20-25 g) and randomly divided into the groups.
SCI model and implantation of the imaging window. We performed all surgical procedures with special attention to sterile conditions. 20 mg/ml ketamine and 2 mg/ml xylazine were administered intraperitoneally to anesthetize the mice. For each moue, the dorsal surface above the thoracic spinal region was shaved with an electric razor and washed with 70% (v/v) ethanol and iodine to reduce the risk of infection. We made a longitudinal incision in the skin at the T11-T13 level of the spine and removed the muscle and tendon tissue from the spinal arcs. After the laminectomy at the level of the T12 segment, we used a sharp scalpel to make a hemisection injury in the spinal cord as previous reported 53, 54 . Briefly, we used stainless clamps of stereotaxic apparatus to immobilize the spinal column, then we used microsurgical forceps and microscissor to tear the dura of the spinal cord segment. A sharp scalpel of 150 mm width was used to cut to the ventral cord on the middle of the spinal cord, and then transected the whole left spinal cord to the lateral side 55 . The average width of the induced injury was 160.8 6 7.3 mm. All the surgery procedure were performed under the stereomicroscope. The surgical manipulation is very reproducible and all the SCI surgeries in present study were performed by the same experienced operator, this could also help to minimize the variation of the lesion size. Because the bleeding was a serious concern for two-photon imaging process, we avoided to damage the dorsal central vein in this model. However, there was bleeding from the injured microvessels after hemisection spinal cord injury. In order to avoid the influence of blood in two-photon imaging process, we cleared the blood from the injured spinal cord by flushing the exposed cord with sterile PBS. After clearing the blood from the lesion site, we implanted a glass window on the mouse spinal cord according to previously described methods 49 . Briefly, we used two metal bars to clamp the three vertebrae on either side of the laminectomy, put the top plate onto the metal bars, and sealed the bone and bars with cyanoacrylate and dental acrylic. Then we applied a layer of silicone elastomer over the spinal cord and placed a glass coverslip over the spinal cord. Finally, we glued the window with dental cement and sutured the skin to the top plate (Fig. 1) . The process of window implantation took 23.4 6 3.5 min after the hemisection injury by an experience operator. After the operation of injury model and window implantation, we randomly divided the animals into different groups without knowing the exact size of the injury and then took the animals to the two-photon microscopy for the first imaging session, we set the 30 min post-injury as the first imaging time in all groups. Postoperatively, mice were kept in a warning pad for several hours until they regained consciousness. We manually voided the bladders of the mice twice daily until voluntary control returned 56 . An antibiotic (enrofloxacin, 2.27 mg/kg, Baytril, Bayer, KS, USA) was used once daily for 3 days. The mice had free access to food and tap water and were maintained on a 12 h light/dark cycle at 22uC 6 1uC.
In vivo imaging of axonal dieback, regional microvascular blood flow, and calcium influx into axons after SCI. To reduce motion artifacts, we positioned each mouse in a customized spinal stabilization device and slightly elevated it to allow room for breathing and chest expansion, as previously described 57 . We used an Olympus FluoView FV1000 two-photon microscope with an Olympus 25 3 1.0 NA water-immersion objective lens. A Spectra Physics Mai-Tai IR laser was tuned to 920 nm for two-photon excitation of YFP and to 890 nm for calcium imaging. Each mouse was kept warm at 37uC during the imaging period. The axonal dieback was a relatively slower event, so we selected the time point at 30 min, 8 h, 24 h, and 48 h post-injury to perform two-photon imaging studies, with the blood vessels labeled with Texas Red dextran (70 kDa) as previous described 58 . Fifteen to twenty axons were measured per animal. We imaged the regional microvascular blood flow as previous reported 59 . After injection of Texas Red dextran into the tail vein, we first mapped the vasculature at the edge of lesion site with a 25 3 1.0 NA water-immersion objective lens. Changes in blood flow and calcium influx was most drastic in the first 2 h post-injury, so we selected the time point at 30, 60, 90, and 120 min post-injury to detect these events with the hope to detect the effect of our pharmacological manipulation. We monitored microvessels of 10-20 mm diameter within 200 mm of the lesion site. Linear scanning along the length of the center of each microvessel was used to measure the velocity of Red Blood Cells (RBCs) at 30 min, 60 min, 90 min, and 120 min post-injury. The RBCs velocity was calculated from the angle of the RBCs streaks 60 . The vascular lumen diameter was measured by the width of the vessels at 30 min, 60 min, 90 min, and 120 min post-injury 18 . For calcium imaging, we used Thy1-GCaMP transgenic mice to investigate intracellular calcium levels in injured axons at 30 min, 60 min, 90 min, and 120 min after SCI. The laser power at the back aperture of the objective was 30 mW at 900 nm at specimen, and the power was constant during all imaging sessions. We measured the fluorescence intensity changes in intracellular calcium levels to evaluate the calcium influx post-injury. Values presented are mean 6 SEM. Repeated measure ANOVA followed by Fisher's LSD.
Image processing and quantification. Image analysis was performed using NIH Image J software. We pseudo-colored and enhanced the contrast of images to increase clarity. We traced the dieback of individual axons in the caudal area. We tracked axons from both three-dimensional stacks to determine the distance between individual axon tips from the initial lesion site. Fifteen to twenty axons were measured per animal to determine the average axonal dieback distance from the edge of the observed injury 49 . The measurements from all animals in each group were averaged to yield the average dieback distance per time point. To evaluate changes of the regional microvascular blood flow velocity, we measured the velocity of RBCs with linear scanning along the length of center of each microvessel, and then calculated the angle of the RBCs streaks. To evaluate calcium influx in the injured axons, we imaged the calcium fluorescence intensity at injured axons in Thy1-GCaMP mice. Changes in [Ca 21 ] i were expressed as changes in fluorescence intensity. (F-F0)/ F0 was used where we defined F as the fluorescence in single axon and F0 as the resting fluorescence signal 20 . Fifteen to twenty axons 200 mm away from the lesion edge were measured individually per animal.
Histology. We performed a histological analysis at the lesion site 3 days post-injury. Animals were deeply anesthetized and perfused transcardially with 20 ml PBS solution, followed by fixation with 20 ml 4% paraformaldehyde (PFA). We immersed the entire spine in 4% PFA for 1 day and then removed the spinal cord from the vertebral canal with microsurgical scissors. The spinal cord was immersed in 30% sucrose until saturated and embedded into optimal cutting temperature (OCT) compound. We froze the spinal cord at 280uC overnight and cut 10 mm sections on a Microm HM 525 cryotome (ThermoFisher Scientific). We blocked with a mixture of 2% goat serum in PBS for 1 h. Next, sections were incubated overnight at 4uC with a primary anti-MAP2 IgG antibody (1:100 dilution; Millipore, USA), anti-F4/80 IgG antibody (1:100 dilution; Biolengend, USA). After incubation with the primary antibody, we rinsed tissue sections in PBS and incubated them with FITC-conjugated anti-mouse fluorescent secondary antibodies (1:100 dilution) for 2 h, and then incubated with DAPI at room temperature for 20 min. Blood vessels were directly labeled by dye DiI (Sigma, USA) as previous reported 61 . Briefly, 100 mg of DiI crystal was dissolved in 16.7 ml of 100% ethanol. After deeply anesthetized the mice, we perfused the mice transcardially with 5 ml DiI solution at a rate of 1-2 ml/min. In this method, DiI molecules were directly incorporated into the membrane of endothelial cells. After DiI staining the blood vessels, the spinal cord was fixed and cut sections as above described. We examined the sections with a fluorescence microscope. Neuronal somata were manually counted based on the morphology of neuron and counter-staining of MAP-2 antibody (red) as well as DAPI (blue). Microvessels were manually counted based on the counterstaining of DiI (red) as well as DAPI (blue). We counted the neurons and microvessels in two rectangular area (0.39 mm 2 ) at the edge of lesion site per section. Three sections per mouse were quantified. Microglia/macrophages were manually counted based on the morphopogy of microglia/macrophages and counter-staining of F4/80 antibody (green) and DAPI (blue). Microglia/macrophages were counted in a rectangular area (5.07 mm 2 ) in the middle of lesion site per section. Three sections per mouse were quantified. Six mice in each group were used.
Protein extraction and Western bolt analysis. Western blots was performed as reported previously 62 . We harvested and froze the injured spinal cord tissue at 270uC and then homogenized the tissue in buffer containing 50 mM Tris-HCl (pH 5 7.4), 1 mM phenylmethysulfonyl (PMSF; Bethesda Research Laboratories, Gaithersburg, MD, USA) and 5 mM EGTA (Sigma) and homogenized with a Polytron batch homogenizer. We centrifuged the homogenized samples in an Optima LE-80K Ultracentrifuge (Beckman Coulter, Fullerton, CA, USA) for 1 h at 100,000 g. After centrifugation, we mixed protein samples with sample buffer and then boiled for 5 min and stored at 220uC. We loaded the samples onto 20% gels and electrophoresed at 200 V for 30 min. We then resolved the proteins and used a Genie transfer apparatus to transfer the samples to nylon membrane. We blocked the nylon membrane for 1 h in 5% nonfat milk in Tris/Tween buffer. We incubated the membranes overnight with primary IgG antibody (1:5000 anti-b-actin (clone AC-15; Sigma), 1:500 anti-active calpain-1 (Abcam, USA), and 1:500 anti-cleaved caspase-3 (Cell Signaling, USA)). We incubated the membranes with donkey anti-rabbit secondary antibody (diluted 1:2000; Biolegend, USA) for 1 h after washing three times with Tris/Tween buffer. We then incubated the membranes with chemiluminescent (ECL) reagent (Amersham, Piscataway, NJ, USA) and exposed www.nature.com/scientificreports SCIENTIFIC REPORTS | 5 : 9691 | DOI: 10.1038/srep09691them to X-Omat AR films (Kodak, Rochester, NY, USA). We scanned the films on a Umax PowerLook Scanner and used Photoshop software (Adobe Systems, Seattle, WA, USA) for image processing. We used Quantity One software (Bio-Rad) to determine the optical density (OD) of each band 40, 62 .
RNA extraction and real-time PCR analysis. We used the RNeasy Mini Kit (Qiagen, Germantown, MD, USA) to isolate the total mRNA from injured spinal cord segments (1 cm containing and surrounding the lesioned area) 3 days after SCI. One milliliter Trizol (Life Technologies) was used to homogenize the tissues, and RNA was extracted according to the manufacturer's protocol. We synthesized cDNA from 1 mg total RNA using iScript cDNA synthesis Kit (Bio-Rad, Hercules, CA, USA) after treatment with DNase (Promega, Madison, WI, USA). We used SYBR-Green based technology to perform real-time PCR in the CFX Connect Real-Time PCR Detection System (Bio-Rad); the following primers were used: nitric oxide synthase 2 (iNOS2) (Fw: AAACCCCAGGTGCTATTCCC; Rv: GAACATTCTGTGCAGTCCCA); monocyte chemoattractant protein 1 (MCP-1):( Fw: ACGCTTCTGGGCCTGT TGTT; Rv: CCTGCTGCTGGTGATTCTCT); Interleukin-1 beta (IL-1b): (Fw: TGGCAACT GTCCCTGAACTC; Rv: GTCGAGATGCTGCTGTGAGA). We analyzed the data using Bio-Rad CFX Manager 3.0 (Bio-Rad). The gene glyceraldehyde-3-phosphate dehydrogenase (GADPH) was chosen as reference. The mRNA level of each target gene was normalized by GADPH and expressed as 2
DCt
(DCt 5 Ct target -Ct GADPH). The relative quantity in mRNA levels of tested genes was determined by the equation: relative quantity 5 1000/2 DCt .
Behavioral testing. We used the Basso Mouse Scale (BMS) score to assess functional recovery after SCI as previously described 63 . Statistical analysis. The statistical analysis was performed using SPSS (version17, SPSS IL, Chicago). Data are presented as mean 6 SEM. We compared axonal dieback distance, microvascular blood flow, vascular lumen diameter, and calcium influx into axons using repeated measure ANOVA followed by Fisher's LSD. We compared number of neurons, microvessels, protein expression, microglia/macrophages, and inflammatory factors using Student's t test. Significant differences were defined at P , 0.05. Highly significant differences were defined at P , 0.01.
Ethical statement. Animal surgical procedures were conducted with the approval of the Animal Experimentation Ethics of the Chinese PLA General Hospital. Care was taken to minimize the number of animals used and their suffering.
